Our research areas:

1- Role of autonomic nervous system and in particular the carotid body (CB), a peripheral chemoreceptor, on the genesis of metabolic disorders

Ribeiro et al. 2013. Diabetes; Sacramento et al. 2017. Diabetologia; Conde et al. 2017 J Physiol; Ribeiro et al. 2018. J Physiol; Conde et al. 2018. Physiol Genomics; Sacramento et al. 2020. IJMS; Cunha-Guimaraes et al. 2020 EJE

2- Modulation of adenosine and/or dopamine signaling/metabolism in insulin-sensitive tissues to ameliorate glucose metabolism and tissue function in metabolic diseases.

Conde et al. 2012. BJN; Guarino et al 2013 Age; Sacramento et al. 2015. EJPS; Sacramento et al. 2020 Front Endoc

3- Exploring molecular players and pathways to promote adipose tissue browning as targets for obesity and type 2 diabetes

4- Modulation of peripheral nerves to treat metabolic diseases, e.g. by the use of bioelectroceuticals

Sacramento et al. 2018 Diabetologia; Cracchiolo et al. 2019 IEEE  

Discover more about Neurometab Group - Instagram - Twitter

Jan 2022 - Jun 2023 – “Moving towards closed-loop bioelectronic medicine for type 2 diabetes: real-time neuromodulation of carotid sinus nerve” Supported by Portuguese Foundation for Science and Technology.  Project Reference: EXPL/MED-NEU/0733/2021. PI: Joana Sacramento

2021-2022: “In the crossroad between metabolic and neurodegenerative diseases” Financiado por: iNOVA4Health - 6,000€ (financiamento para  2021). PI: Silvia V. Conde e Hugo Vicente Miranda.

Aug 2016 - June 2019 - “The Carotid Body as a therapeutic target in metabolic diseases: Mapping carotid sinus nerve activity in diabetes rat models: Lisbon Stage 2”. supported by: Galvani Bioelectronics - 340.316,00€ - PI: Sílvia Conde

Nov 2013 - Apr 2016 - “The Carotid Body as a therapeutic target in metabolic diseases: Mapping carotid sinus nerve activity in diabetes rat models”. supported by: GSK Bioelectronic Exploratory Funding - 147.905,56€ PI: Sílvia Conde

Mar 2015 - Apr 2016 - "Wireless Interfacing of the Carotid Sinus Nerve for Hypoxic Response Modulation". Collaboration project between CEDOC, NOVA Medical School, University of Texas and Illinois Institute of Technology. Supported by: GSK Innovation Challenge Funding. 200.000$ (total), 49.728$ (Silvia Conde). co-PIs: Mário Romero and Sílvia Conde

Mar 2014 - Feb 2015 – “Mapping the sympathetic efferent activity in carotid-body mediated insulin resistance”. Supported by: Portuguese Foundation for Science and Technology (EXPL/NEU-SCC/2183/2013) – 48.371€ PI: Maria Guarino

Nov 2013 - Nov 2014 - "Mapping carotid sinus nerve activity in diabetes rat models" Supported by: GSK Bioelectronic Exploratory Funding Ref: D00006317 - 96.105$ PI: Silvia Conde

Mar 2011 - Dec 2013 - "Insulin and carotid body: a new mechanism for insulin resistance and hypertension.".Supported by Portuguese Foundation for Science and Technology Project Reference: PTDC/SAU-ORG/11149/2009 - 100.000€ PI: Silvia Conde

Nov 2009 - May 2012: Effect of chronic caffeine intake on insulin resistance and hypertension: mechanistic and therapeutic approach. Supported by: Sociedade Portuguesa Diabetologia/Lilly Portugal - 10.000 € PI: Silvia Conde and Maria Guarino

- Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function

- Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes

- Chronic Intermittent Hypoxia Induces Early-Stage Metabolic Dysfunction Independently of Adipose Tissue Deregulation

- Carotid body chemosensitivity: early biomarker of dysmetabolism in humans

- Bioelectronic modulation of carotid sinus nerve activity in the rat: a potential therapeutic approach for type 2 diabetes

• Tavares G, Martins FO, Melo BF, Matafome P, Conde SV. Peripheral Dopamine Directly Acts on Insulin-Sensitive Tissues to Regulate Insulin Signaling and Metabolic Function. 
  Front Pharmacol. 2021 Sep 9;12:713418. doi: 10.3389/fphar.2021.713418.
• Martins FO, Sacramento JF, Olea E, Melo BF, Prieto-Lloret J, Obeso A, Rocher A, Matafome P, Monteiro EC, Conde SV. Chronic Intermittent Hypoxia Induces Early-Stage Metabolic Dysfunction Independently of Adipose Tissue Deregulation. 
  Antioxidants (Basel). 2021 Jul 30;10(8):1233. doi: 10.3390/antiox10081233.
• Tavares G, Marques D, Barra C, Rosendo-Silva D, Costa A, Rodrigues T, Gasparini P, Melo BF, Sacramento JF, Seiça R, Conde SV, Matafome P. Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes. 
  Mol Metab. 2021 Sep;51:101241. doi: 10.1016/j.molmet.2021.101241.
• Melo BF, Prieto-Lloret J, Cabral MD, Martins FO, Martins IB, Sacramento JF, Ruivo P, Carvalho T, Conde SV. Type 2 diabetes progression differently affects endothelial function and vascular contractility in the aorta and the pulmonary artery. Sci Rep. 2021 Mar 15;11(1):6052. doi:10.1038/s41598-021-85606-7
• Falvey A, Duprat F, Simon T, Hugues-Ascery S, Conde SV, Glaichenhaus N, Blancou P. Electrostimulation of the carotid sinus nerve in mice attenuates inflammation via glucocorticoid receptor on myeloid immune cells. 
  J Neuroinflammation. 2020 Dec 2;17(1):368. doi: 10.1186/s12974-020-02016-8
• Cunha-Guimaraes JP, Guarino MP, Timóteo AT, Caires I, Sacramento JF, Ribeiro MJ, Selas M, Santiago JCP, Mota-Carmo M, Conde SV. Carotid body chemosensitivity: early biomarker of dysmetabolism in humans. Eur J Endocrinol. 2020 Jun;182(6):549-557.
• Sacramento JF, Chew DJ, Melo BF, Donegá M, Dopson W, Guarino MP, Robinson A, Prieto-Lloret J, Patel S, Holinski BJ, Ramnarain N, Pikov V, Famm K, Conde SV (2018). Bioelectronic modulation of carotid sinus nerve activity in the rat: a potential therapeutic approach for type 2 diabetes. Diabetologia 61:700-710.
• Sacramento JF, Ribeiro MJ, Rodrigues T, Olea E, Melo BF, Guarino MP, Fonseca-Pinto R, Ferreira CR, Coelho J, Obeso A, Seiça R, Matafome P, Conde SV. (2017). Functional abolition of carotid body activity restores insulin action and glucose homeostasis in rats: key roles for visceral adipose tissue and the liver. Diabetologia 60:158-168; doi: 10.1007/s00125-016-4133-y.
• Ribeiro MJ, Sacramento JF, Gonzalez C, Guarino MP, Monteiro EC, Conde SV. (2013). Carotid body denervation prevents the development of insulin resistance and hypertension induced by hypercaloric diets. Diabetes. 62:2905-16; doi: 10.2337/db12-1463. 

2021 Prémio de Investigação Alfredo da Silva: “CB meter – um novo dispositivo para a deteção o precoce da diabetes mellitus tipo 2”, Fundação Amélia de Mello, Portugal.

2021 Award Pedro Eurico Lisboa to the best paper in the Diabetes field: Carotid body chemosensitivity: early biomarker of dysmetabolism in humans. Joao P Cunha-Guimaraes et al. 2020 Eur J Endocrin 182: 549-557.

2021 Best Oral Communication in the field of Fundamental Research in the 17th Portuguese Congress of Diabetes. 

2020 Best poster communication in the category of nutrition by the Portuguese Society for the study of Obesity (SPEO) in the 24th Portuguese Obesity Congress. 

2020 Honor award for the poster communication in the category of Obesity and its Comorbidities by the Portuguese Society for the study of Obesity (SPEO) in the 24th Portuguese Obesity Congress. 

2019 Eurico Lisboa Honor Award from the Portuguese Society of Diabetes- Best publication in the Diabetes: Bioelectronic modulation of carotid sinus nerve activity in the rat: a potential therapeutic approach for type 2 diabetes. Sacramento et al. 2018 Diabetologia 61:700-710.

2018 Pulido Valente/FCT Award – Best publication in Biomedical Engineering “Bioelectronic modulation of carotid sinus nerve activity in the rat: a potential therapeutic approach for type 2 diabetes.” Sacramento et al. 2018 Diabetologia 61:700-710

2017 Eurico Lisboa Award from the Portuguese Society of Diabetes- Best publication in the Diabetes field “Functional abolition of carotid body activity restores insulin action and glucose homeostasis in rats: key roles for visceral adipose tissue and the liver. Sacramento et al. 2017 Diabetologia. 60:158-168

2017 1st Prize “De Castro-Heymans- Neil Award” by ISAC (International Society for Arterial Chemoreception) to the best work presented by a Young Research each triennial ISAC Meeting. (to Joana F. Sacramento)

2016 National Diabetes Award 2016 from the Portuguese Society of Diabetes

2016 Hargreaves 2016 Award from the Portuguese Society of Diabetes/JABA RECORDATI

2014 Best project in the Translational Research category by Fundação AstraZeneca Innovate Competition. (to Bernardete Melo)

2014 1st Prize “De Castro-Heymans- Neil Award” by ISAC (International Society for Arterial Chemoreception) to the best work presented by a Young Research each triennial ISAC Meeting. ( to Maria João Ribeiro)

2014 EPHAR Young Investigator Award from the Federation of European Pharmacological Societies to best scientific article published in the area of pharmacology. (to Maria João Ribeiro)

2012 Hargreaves 2012 Award from the Portuguese Society of Diabetes /JABA RECORDATI
2009 L’Oreal Portugal Medals of Honour for Women in Science from L’Oreal, Portuguese Science and Technology Foundation and UNESCO (to Silvia conde)

2009 Nuno Castel Branco Award from the Portuguese Society of Diabetes and Lilly Portugal (to Silvia Conde and Maria Guarino)

• Conde SV, Chew DJ, Famm K, Guarino MP, Holinski B, Patel S (2015) Neuromodulation device. Patent PCT/PT2015/000047. International Bureau WO/2016/072875. Licensed to Galvani Bioelectronics in May 2016. 
• Micera S, Panarese A, Mazzoni A, Carpanato J, Cracchiolo M, Ramnarain N, Conde SV (2017) A SYSTEM FOR MONITORING AND TREATING METABOLIC DISORDERS. Patent No. 102017000148492

• Maria Guarino e Rui-Fonseca Pinto, CiTechCare, Instituto Politecnico de Leiria, Leiria, Portugal
• Paulo Matafome eRaquel Seiça – iCBR , Coimbra Institute for Clinical and Biomedical Research, Coimbra, Portugal
• Helena Vieira – Cell Death and Disease group, Faculdade Ciências e Tecnologia
• Phillipe Blancou and Nicolas Glaichenhaus: Institut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur, Nice, França - 
• Phill Miliken, Galvani Bioelectronics - GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, UK- 
• Silvestro Micera:  Sant'Anna School of Advanced Studies, Pisa, Itália 
• Mario Romero: Department of Biomedical Engineering, University of Houston, Houston, TX, USA
• Ana Obeso, Asuncion Rocher, Elena Olea, Jesus Prieto-Lloret - Faculty of Medicine, University of Valladolid, Spain